Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5289777

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C=C(F)C(=O)N1CCN(c2nc(O[C@@H]3CCCN3CCCOCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)nc3c2CCN(c2cccc4cccc(Cl)c24)C3)C[C@H]1CC#N

Basic Information

ChEMBL ID CHEMBL5289777
Phase Preclinical
Structure Type MOL
InChI Key FTSNKXXRMZUQSC-AUYKJQTJSA-N
1
Targets
5
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

1118.8
MW (Da)

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C58H69ClFN11O7S
MW 1118.78

Activity Summary

EC50 5 meas. best 6.6

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
von Hippel-Lindau disease tumor suppressor/KRAS
CHEMBL5169273
EC50 6.6 6.6 250.0 5

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
36274273 10.1016/j.ejmech.2022.114838 von Hippel-Lindau disease tumor suppressor/KRAS 5

Data from ChEMBL 36 via Core Engine